Medical News

RSS

Synexus completes CT327 phase II psoriasis trial for Creabilis

Synexus has completed a phase II study for the European biotech, Creabilis, recruiting 26 patients in the UK to the psoriasis trial of its CT327 lead product in just 2 weeks, as part of an international proof-of-concept study. The company delivered the targeted number of patients well within the agreed timelines and budget.

From AES - Accelerated Enrollment Solutions 16 May 2011

Counterfeit medicines posing increasing risk to patients worldwide, U.N. agency says

Counterfeit medications are posing an increasing threat to patients' health worldwide, because they offer high returns and low risks for criminal organizations, the U.N. Office on Drugs and Crime said in a statement on Friday, Agence France-Presse reports.

16 May 2011

Simple, minimal invasive technique could help detect early-stage lung cancer

A simple, minimally-invasive technique using cells from the interior of the nose could help clinicians detect lung cancer in its earliest - and most treatable - stages, according to a study conducted by researchers in Boston.

16 May 2011

New lenalidomide phase III study data presented at 13th International Myeloma Workshop

Updated data from a National Cancer Institute-sponsored clinical trial conducted by the Cancer and Leukemia Group (CALGB) was presented May 5 at the 13th International Myeloma Workshop in Paris, France.

16 May 2011

NewGene develops breakthrough test for hereditary breast cancer

A new breakthrough test for hereditary breast cancer developed by UK-based NewGene could see thousands of women being diagnosed with the genetic condition in around half the usual time and at around half the cost of conventional test methods.

16 May 2011

Report calls for developing new methods of contraception for women in developing countries

Women in the developing world need new methods of contraception that meet their needs and lifestyles, according to a Guttmacher Institute report that urges more investment in contraceptive technology, Agence France-Presse reports.

16 May 2011

New York Academy of Sciences and Zeltia to host marine drug discovery forum on May 20, 2011

Substances produced by living organisms found in nature-so-called "natural products"-have played a critical role in the development of drugs for life-threatening conditions. The anticancer agent Taxol was sourced from a plant, penicillin from a fungus, and a number of recent breakthroughs have resulted in the development and approval of anticancer drugs derived from marine sources such as coral and sponges.

16 May 2011

Study reveals role of KLF14 regulatory gene in type 2 diabetes

A team of researchers, led by King's College London and the University of Oxford, have found that a gene linked to type 2 diabetes and cholesterol levels is in fact a 'master regulator' gene, which controls the behaviour of other genes found within fat in the body.

16 May 2011

Karo Bio symposium to discuss research on ER-beta and therapeutic applications

Karo Bio AB is organizing a symposium in Stockholm on May 16-17, where key researchers from the industry and the academic community present and discuss the frontier of research in the field of estrogen receptor beta (ER-beta) and its therapeutic applications.

16 May 2011

Global health Product Development Partners consortium select GVK BIO as preferred provider

GVK Biosciences, Asia's leading drug discovery research & development organization announced today that it has been selected as a preferred provider to a consortium of 14 global Product Development Partners (PDPs) for clinical services in Asia. GVK BIO is the only partner that is headquartered in India.

16 May 2011

Romney's defense of Massachusetts health plan triggers political questions

In what was billed as a major health care speech, Mitt Romney defended his state's plan but distanced himself from the federal health law, despite many similarities to the law Mitt Romney signed while governor. The circumstances have him walking a political tightrope.

16 May 2011

Pre-existing malaria prevents secondary infection by another Plasmodium strain

A team of researchers have found that pre-existing malaria prevents secondary infection by another Plasmodium strain, the parasite responsible for malaria, by restricting iron availability in the liver of the host.

16 May 2011

Study to examine population rates of ED use for adults with intellectual and developmental disabilities

In the first North American study to examine population rates of Emergency Department (ED) use for adults with intellectual and developmental disabilities (IDD), researchers from the Institute for Clinical Evaluative Sciences (ICES) and the Centre for Addiction and Mental Health (CAMH) found 55 per cent of adults with IDD and mental illness visited the ED at least once in a 2 year period and 15.6 per cent visited at least 5 times.

16 May 2011

Early HIV treatment can reduce transmission risk by 96%, preliminary study results show

Preliminary results from a multicountry clinical trial, sponsored by the National Institute for Allergy and Infectious Diseases (NIAID), show that HIV-positive people who take combination antiretroviral therapy (ART) can reduce the risk of transmitting the virus to their HIV-negative partners by 96 percent, U.S. researchers announced on Thursday " in what is being hailed as a breakthrough in HIV prevention," the Los Angeles Times reports.

16 May 2011

Scientists discover single neuron that enables adaptive regulation of sparseness in olfactory codes

The brain is a coding machine: it translates physical inputs from the world into visual, olfactory, auditory, tactile perceptions via the mysterious language of its nerve cells and the networks which they form. Neural codes could in principle take many forms, but in regions forming bottlenecks for information flow or in areas important for memory, sparse codes are highly desirable.

16 May 2011

Continuous positive airway pressure reduces cardiovascular mortality in elderly OSA patients

Continuous positive airway pressure (CPAP) effectively decreases the risk of cardiovascular death in elderly patients who suffer from obstructive sleep apnea (OSA), according to a study conducted by researchers in Spain.

16 May 2011

With next election in mind, Medicare politics among the dynamics similar to 2010 congressional contests

Some news outlets report that "what goes around comes around" as many House Republicans are being reminded of the last election's raucous town hall meetings — this time, though, they are in the hot seat. Meanwhile, members of the GOP freshmen class have asked the White House to condemn liberal attacks on the Medicare proposal advanced by Rep. Paul Ryan, R-Wis.

16 May 2011

Australian TGA approves Biogen Idec's FAMPYRA to improve walking ability in patients with MS

The Australian Therapeutic Goods Administration (TGA) has granted approval for FAMPYRA, (fampridine) 10 mg Modified Release (MR) tablet, for the symptomatic improvement of walking ability in adult patients with multiple sclerosis (MS) who have shown improvement after eight weeks of treatment.

16 May 2011

Loyola earns Joint Commission certification for heart pump therapy

Loyola University Hospital has been certified by the Joint Commission to begin implanting heart pumps known as left ventricular assist devices (LVADs) as permanent therapy for advanced heart failure.

16 May 2011

Researchers discover depression-related DNA region

Researchers at Washington University School of Medicine in St. Louis and King's College London have independently identified DNA on chromosome 3 that appears to be related to depression.

16 May 2011

Medical News

Synexus completes CT327 phase II psoriasis trial for Creabilis

Counterfeit medicines posing increasing risk to patients worldwide, U.N. agency says

Simple, minimal invasive technique could help detect early-stage lung cancer

New lenalidomide phase III study data presented at 13th International Myeloma Workshop

NewGene develops breakthrough test for hereditary breast cancer

Report calls for developing new methods of contraception for women in developing countries

New York Academy of Sciences and Zeltia to host marine drug discovery forum on May 20, 2011

Study reveals role of KLF14 regulatory gene in type 2 diabetes

Karo Bio symposium to discuss research on ER-beta and therapeutic applications

Global health Product Development Partners consortium select GVK BIO as preferred provider

Romney's defense of Massachusetts health plan triggers political questions

Pre-existing malaria prevents secondary infection by another Plasmodium strain

Study to examine population rates of ED use for adults with intellectual and developmental disabilities

Early HIV treatment can reduce transmission risk by 96%, preliminary study results show

Scientists discover single neuron that enables adaptive regulation of sparseness in olfactory codes

Continuous positive airway pressure reduces cardiovascular mortality in elderly OSA patients

With next election in mind, Medicare politics among the dynamics similar to 2010 congressional contests

Australian TGA approves Biogen Idec's FAMPYRA to improve walking ability in patients with MS

Loyola earns Joint Commission certification for heart pump therapy

Researchers discover depression-related DNA region

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest News